Ossium Health, a bioengineering company leveraging stem cell science to develop treatments for diseases of the blood and immune systems, has been named as a winner of the Inc. 2023 Best in Business award. This award recognizes dynamic companies that made an extraordinary positive impact on their communities, their industries, the environment, or society as a whole in the past year. Ossium was named a winner in two categories: Health Products, which honors companies producing healthcare products, and Lean and Mean, which honors companies with annual gross revenues under $5m.
“We’re honored to receive an award that recognizes the progress Ossium has made toward our mission of improving human health through bioengineering,” said Kevin Caldwell, Ossium’s CEO, Co-Founder and President. “We’re proud to be listed alongside an impressive group of companies that make a positive impact on the world.”
Eric Hagerman, Special Projects Editor at Inc., said, “Being named to the Best in Business list is a rare and special honor. These honorees demonstrate the foresight, caring, and dedication to prioritize positive impact—impact on their community, on their industry and the environment, and even on society as a whole.”
To choose the companies named as Best in Business, Inc.’s editors reviewed companies’ achievements over the past year and noted how they made a positive difference in the world. They selected winners in 70 different categories based on industry, age, revenue, size, and impact. The list of companies receiving this award can be found at inc.com/best-in-business and in the Winter issue of Inc. magazine hitting newsstands on December 12th.
About Ossium Health
Ossium Health is a bioengineering company that leverages its proprietary organ donor bone marrow banking platform to develop stem cell therapies for patients with life-threatening blood and immune diseases. Founded in 2016, the company is led by Kevin Caldwell, CEO, Co-Founder & President, and Erik Woods, Chief Science Officer, Co-Founder & EVP. Ossium Health’s manufacturing facility is registered with the FDA and its laboratory is certified under the Clinical Laboratory Improvement Amendment (CLIA).
About Inc.
The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community they need to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest- growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit www.inc.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231205789667/en/
Contacts
Geney Park
Ossium Health, Inc.
415-513-5535
press@ossiumhealth.com
